Related Experiment Video
Updated: Dec 17, 2025

07:08
Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
Published on: February 2, 2024
1.2K
Neoadjuvant Treatment for Pancreatic Cancer: Still a Controversial Issue?
Si Shi1, Jie Hua1, Xianjun Yu1
1Si Shi, MD; Jie Hua, MD and Xianjun Yu, MD, PhD, Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
Abstract
No abstract available in PubMed .

